Originally posted by Bretsky
View Post
I think I mentioned RPRX here before. They buy drug patents (some already on the market, some as early as stage 2 trials). This is a brilliant model and the stock was trading at 6.3x just yesterday (today naturally as I type this it announced some corporate moves and popped 12%). This is a no brainer 15x stock imo so you should have a stranglehold on 10% with very possible double or more in the next few years.
NRXP is a true gamble. I bought it at $1.50 with about .2% of my net worth. Thats how risky it is, but in just over a month its up to $4.80. Too late?? Depends on the time line. I expect $15 within a couple years if they move forward on the partnerships they are building with some bigger companies. Sometimes even though a stocks technicals are beyond my knowledge base (they are working on some neurotherapies) I can look at the leadership and how savvy they are at building partnerships. These guys are good. If they deliver on PTSD therapies a 400% return is almost a lock. But remember, if they fail zero is also possible.
ARDX is a stock I'm not in yet, and might still buy. Going for just over $5 a share and showing no profit, analysts (who are not bad for a stock like this) project near a $1 profit per share within 3 years (triggered by 400% growth in 2026). Stock has been around for a long time and was $25 in 2014 (which is where a lot of AI stocks are now and which is what I was saying about biotech pricing in 20 year promises back in 2000). I haven't done enough research yet, but they work on affecting how we absorb nutrients (yes, the bad ones especially) within our digestive tract. If you think the semiglutides are big, wait until a company can simply stop you from absorbing sodium or cholesterol. Again, I have no skin in this game yet and may not ever.
I'm generally a little early on things, and hedgefunds aren't in biotech right now, but that doesn't mean they won't be, and if/when big money piles into these stocks instead of reaching "fair" valuations of 15-25x the hype could drive them to stupid values like 50x. Just think if you buy a stock with 400% return to fair value and it then goes another 300% from that point. Problem is I'll start bleeding as they reach fair value and never actually get the 12 bagger. Its just my nature.

Leave a comment: